Tunalı, İlke.
(Thesis (Ph.D.)-Bogazici University. Institute of Biomedical Engineering, 2020., 2020.)
Checkpoint blockade immunotherapy (IO) provides improved long-term survival in a subset of advanced stage non-small cell lung cancer (NSCLC) patients. However, highly predictive biomarkers of IO response are an unmet ...